Business Details
27 Years
experience
Cumberland Phamaceuticals: Advancing Patient Care Through Innovation
Cumberland Phamaceuticals is dedicated to advancing patient care through the development and commercialization of FDA-approved, high-quality prescription medicines. Since our founding in 1999, we have focused on addressing critical unmet medical needs by delivering innovative therapies for conditions such as acetaminophen overdose, post-operative pain, chemotherapy-induced nausea, and rare diseases like Duchenne muscular dystrophy.Our commitment to research and development drives our pipeline of investigational treatments for fibrosis, cardiomyopathy, and autoimmune disorders. By forming strategic partnerships globally, we ensure our products reach patients in the U.S. and key international markets, including China, Saudi Arabia, and Australia. Our team combines decades of pharmaceutical expertise with a patient-centric approach to improve healthcare outcomes.
Services
Acetadote
Caldolor
Kristalose
Sancuso
Vaprisol
Vibativ
Dyscorban
Fibroban
Vasculan
Details
- Year established: 1999
Highlights and features
- We have over two decades of experience in developing FDA-approved therapies for unmet medical needs.
- Our product portfolio addresses acute care, rare diseases, and oncology with patented formulations.
- We maintain rigorous quality standards through partnerships with global regulatory bodies.
- Our dedicated oncology sales division ensures specialized support for complex treatments.
- We prioritize patient safety with transparent clinical data and adherence to FDA guidelines.
Services
Acetadote
Acetadote (acetylcysteine) is an intravenous treatment for acetaminophen overdose, a leading cause of drug toxicity in the U.S. It prevents or reduces liver damage in emergency and hospital settings, offering a safe, EDTA-free formulation approved for adult and pediatric use. Clinical studies demonstrate its efficacy in critical care scenarios.
Caldolor
Caldolor (ibuprofen) injection treats pain and fever in adults and pediatric patients. As the first FDA-approved injectable ibuprofen, it reduces opioid dependence post-surgery by acting both peripherally and centrally. Available in vial and ready-to-use bag formulations, it simplifies administration.
Sancuso
Sancuso (granisetron) is a transdermal patch preventing chemotherapy-induced nausea and vomiting (CINV). Applied 2448 hours before treatment, it delivers continuous medication for up to five days, offering a convenient alternative to oral therapies requiring frequent dosing.
Vibativ
Vibativ (telavancin) injection targets serious bacterial infections, including MRSA and multidrug-resistant strains. Its dual mechanism treats hospital-acquired pneumonia and skin infections, with clinical data showing enhanced lung tissue penetration, particularly beneficial for secondary infections in critical care patients.
Dyscorban
Dyscorban (ifetroban) oral capsules address cardiomyopathy in Duchenne muscular dystrophy patients. With FDA orphan drug designation, this investigational therapy reduces cardiac fibrosis and improves survival in preclinical studies. Phase II trials demonstrated efficacy in managing this fatal genetic condition.
People
A.J. Kazimi
Chief Executive Officer
A.J. Kazimi leads Cumberland Phamaceuticals with a focus on advancing therapies for rare diseases. Recognized as a top industry leader, he has driven the company's growth through strategic partnerships and innovation in acute care and oncology for over 15 years.
Questions
What therapeutic areas does Cumberland Pharmaceuticals focus on?
We specialize in acute care, rare diseases, and oncology, with FDA-approved products addressing pain management, antibiotic resistance, and fibrotic conditions.
How does Sancuso differ from oral nausea medications?
Sancuso is a once-applied patch preventing chemotherapy-induced nausea for up to five days, eliminating the need for frequent oral dosing.
What clinical trials are currently active for Cumberland's pipeline products?
Phase II studies for Dyscorban (Duchenne cardiomyopathy), Fibroban (idiopathic pulmonary fibrosis), and Vasculan (systemic sclerosis) are underway.
Where are Cumberland's products available internationally?
Products like Caldolor and Vibativ are commercialized in China, Saudi Arabia, Australia, and other regions through partnerships.
How does Cumberland ensure product quality and safety?
We adhere to FDA regulations, conduct rigorous clinical trials, and collaborate with global partners to maintain high safety and efficacy standards.
